why choose us

First received: July 02, 2024

Clinical Trial: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Metabolic Dysfunction-associated Steatotic Liver Disease

Study Type: OBSERVATIONAL


Official Title: Epidemiologic Liver Outcomes Retrospective Study to Confirm The Prognostic Value of the FibroNest Digital Pathology Fibrosis Biomarker (Ph-FCS) in Patients With MASLD (DPAILO-2)

Brief Summary: The aim of this multi-center, retrospective epidemiologic study is to confirm the prognostic performance of the Digital Pathology (DP) FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS), derived from standard digital pathology liver biopsy images, in predicting clinical hepatic decompensation events in patients with metabolic dysfunction-associated steatohepatitis (MASH).

Read more